Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 2000

View Archived Issues

Synsorb Pk receives fast track designation from FDA for prevention of HUS

Enrollment in Altropane PD diagnosis trial now complete

InSite Vision's batimastat eyedrops show antiangiogenic activity

Decitabine effective in myelodysplastic syndrome

Visudyne T-IND program expanded

Medicure's MC-1 shows good results in ischemia models

More good news about Enbrel: NEJM article describes efficacy in juvenile RA

NeoPharm receives milestone payment from P&U for LEP

FDA grants priority review for new once-daily Videx capsules

Calcilytic compounds described by SB for use in disorders of bone or mineral homeostasis

ODAC does not recommend approval of oxaliplatin combination therapy

Novartis discloses new antiangiogenic agents acting on growth factor-mediated signal transmission

Medivir reinitiates development of alovudine for AIDS

New 9-aminocamptothecins endowed with potent antitumor activity

Subtype-selective PDE4 inhibitors claimed by Pfizer for respiratory and other disorders

Phase II results positive for Medivir's shingles antiviral

AstraZeneca pipeline includes novel chemokine receptor modulators

Abbott's new alpha1A-adrenoceptor agonists, their preparation, activity and use

Whole genome sequencing of N. meningitidis leads to novel vaccine candidates

German launch for Mifegyne announced

FDA advisory committee recommends approval of Camptosar as first-line therapy of colorectal cancer

New PDT candidate designed by Chinese university researchers

Memory-enhancing effects of huperzine tablets and capsules proven equivalent

Cariporide: no improvement in myocardial stunning/infarct size in GUARDIAN trial subgroup

TxA2 antagonist from Bayer may have potential in atherosclerosis according to ACC presentation

First human data reported for GI-262570 at recent scientific forum

Licensing opportunity from Vita-Invest: fixed-dose antihypertensive combination

Potential for drug interactions of Sch-58235 evaluated in humans

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...